
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Go With The Breeze: Grand Paragliding Spots On the planet - 2
Crypto Investor’s Family Tied Up and Beaten by Armed Gangs in Their Home - 3
Record-breaking 'space laser' erupts from merging galaxies 8 billion light-years away - 4
Figure out How to Pick a Crematorium: Key Contemplations. - 5
Lilly, Novo lock horns in India's obesity drug race
Pick the Ideal Family Feline Variety for Your Home
'Euphoria' Season 3 trailer includes Eric Dane's final appearance, Jacob Elordi and Sydney Sweeney at the altar and Rue's 'Breaking Bad' era
This is Countdown, CNN’s newsletter covering NASA’s first time sending humans to deep space in over 50 years
Make your choice for the music application with the most amicable connection point!
Posts falsely claim Netanyahu video fabricated to cover up his death
Step by step instructions to Protect Your Speculations with Cd Rates
Ukrainian foreign minister appeals for funds for drones
Warning for snow and ice extended
Jeff Bezos’ Blue Origin launches landmark Mars mission in New Glenn rocket’s first big test













